Received Mar 2, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | UNK | — | OT |
Her arm felt normal soreness afterwards; there is a small painful bump at the injection site; This spontaneous report was received from a Consumer and refers to a female patient of unknown age. The patient's medical history, concurrent conditions, concomitant therapies, drug reactions or allergies were not reported. On an unspecified date in February 2026 (reported as last week), the patient was vaccinated with a dose of Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL®9) 0.5 mL (lot #, expiration date, route of administration not provided) in the deltoid (unspecified side) as prophylaxis. On an unspecified date in February 2026, the patient experienced normal arm soreness afterwards, and a small painful bump at the injection site still a week later. At the reporting time, the outcome of arm soreness and bump at injection site was unknown. The causal relationship between both events and Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL®9) was not reported.